379 related articles for article (PubMed ID: 10674444)
1. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.
Haigh PI; Hansen NM; Qi K; Giuliano AE
Ann Surg Oncol; 2000; 7(1):21-7. PubMed ID: 10674444
[TBL] [Abstract][Full Text] [Related]
2. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.
Nason KS; Anderson BO; Byrd DR; Dunnwald LK; Eary JF; Mankoff DA; Livingston R; Schmidt RA; Jewell KD; Yeung RS; Moe RE
Cancer; 2000 Dec; 89(11):2187-94. PubMed ID: 11147588
[TBL] [Abstract][Full Text] [Related]
3. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
Chung MH; Ye W; Giuliano AE
Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
5. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
Salmon RJ; Fried D
Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
[TBL] [Abstract][Full Text] [Related]
6. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
Pargaonkar AS; Beissner RS; Snyder S; Speights VO
Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
9. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
10. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.
Olaya W; Wong J; Wong J; Morgan J; Kazanjian K; Lum S
Ann Surg Oncol; 2013 Feb; 20(2):627-32. PubMed ID: 22956069
[TBL] [Abstract][Full Text] [Related]
11. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
[TBL] [Abstract][Full Text] [Related]
12. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer.
Ozmen V; Muslumanoglu M; Cabioglu N; Tuzlali S; Ilhan R; Igci A; Kecer M; Bozfakioglu Y; Dagoglu T
Breast Cancer Res Treat; 2002 Dec; 76(3):237-44. PubMed ID: 12462384
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
14. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.
Giuliano AE; Haigh PI; Brennan MB; Hansen NM; Kelley MC; Ye W; Glass EC; Turner RR
J Clin Oncol; 2000 Jul; 18(13):2553-9. PubMed ID: 10893286
[TBL] [Abstract][Full Text] [Related]
15. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
16. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
18. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
19. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M
Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]